Corticosteroids do not prevent optic nerve atrophy following optic neuritis.
Hickman
S J
SJ
NMR Research Unit, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.
Kapoor
R
R
Jones
S J
SJ
Altmann
D R
DR
Plant
G T
GT
Miller
D H
DH
D000328:Adult; D005074:Evoked Potentials, Visual / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D009896:Optic Atrophy / Q000175:diagnosis / Q000517:prevention & control*; D009900:Optic Nerve / Q000187:drug effects / Q000473:pathology; D009902:Optic Neuritis / Q000175:diagnosis / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D008775:Methylprednisolone